跳至主要内容
临床试验/PACTR202204558879194
PACTR202204558879194已完成未知

The impact of different doses of intrathecal dexmedetomidine used as adjuvant to hyperbaric prilocaine in short ambulatory procedures under spinal anaesthesia: a randomized controlled study

AFCM0 个研究点目标入组 69 人开始时间: 2022年4月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
69

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Adult patients (18-65 years).
  • Both genders
  • ASA I-II.
  • Patients scheduled for elective surgeries under spinal anaesthesia.

排除标准

  • Patients with impaired mental status.
  • Patients with body mass index <18 or > 35 kg/m2.
  • Patients suffering from coagulation disorders.
  • Patients with histories of allergic reactions to local anesthetics or dexmedetomidine.
  • Patients suffering from severe cardiac, respiratory, hepatic, renal or neuropsychiatric disorders.
  • Patients with histories of chronic use/abuse of sedatives, narcotics, and of alcohol or other drug abuse.

研究者

发起方
AFCM

相似试验